Nuvation Bio stockholders elect directors, ratify auditor, approve say-on-pay at 2025 annual meeting

Nuvation Bio Inc.

All three proposals passed at May 21, 2025 annual meeting; quorum of 82.8% of Class A shares present.
Kathryn E. Falberg elected Class A director with 198.6M for, 18.0M withheld; David Hung elected Class B director with 1.0M for.
Ratification of KPMG LLP as auditor for FY2025: 279.9M for, 1.6M against, 15.8K abstain.
Advisory approval of named executive officer compensation: 214.9M for, 1.6M against, 143.8K abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.